Show item record

dc.contributor.authorChatauret, Nicolas
dc.contributor.authorRose, Christopher
dc.contributor.authorButterworth, Roger
dc.date.accessioned2013-04-25T20:51:12Z
dc.date.available2013-04-25T20:51:12Z
dc.date.issued2002-12
dc.identifier.urihttp://hdl.handle.net/1866/9591
dc.subjectAcide glutamiqueen
dc.subjectAcide lactiqueen
dc.subjectAcute liver failureen
dc.subjectAmmoniaen
dc.subjectAmmoniacen
dc.subjectBrain edemaen
dc.subjectCerebral blood flowen
dc.subjectDéfaillance hépatique aigüeen
dc.subjectGlutamateen
dc.subjectGlutamineen
dc.subjectHypothermiaen
dc.subjectHypothermieen
dc.subjectLactateen
dc.titleMild hypothermia in the prevention of brain edema in acute liver failure: mechanisms and clinical prospects
dc.typeArticleen
dc.contributor.affiliationUniversité de Montréal. Faculté de médecinefr
dc.contributor.affiliationUniversité de Montréal. Faculté de médecine. Centre de recherche du CHUMfr
dc.identifier.doi10.1023/A:1021982523691
dcterms.abstractMild hypothermia (32 degrees C-35 degrees C) reduces intracranial pressure in patients with acute liver failure and may offer an effective adjunct therapy in the management of these patients. Studies in experimental animals suggest that this beneficial effect of hypothermia is the result of a decrease in blood-brain ammonia transfer resulting in improvement in brain energy metabolism and normalization of glutamatergic synaptic regulation. Improvement in brain energy metabolism by hypothermia may result from a reduction in ammonia-induced decrease of brain glucose (pyruvate) oxidation. Restoration of normal glutamatergic synaptic regulation by hypothermia may be the consequence of the removal of ammonia-induced decreases in expression of astrocytic glutamate transporters resulting in normal glutamate neurotransmitter inactivation in brain. Randomized controlled clinical trials of hypothermia are required to further evaluate its clinical impact.en
dcterms.languageengen
UdeM.VersionRioxxVersion acceptée / Accepted Manuscript
oaire.citationTitleMetabolic brain disease
oaire.citationVolume17
oaire.citationIssue4
oaire.citationStartPage445
oaire.citationEndPage451


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show item record

This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.